{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:46:55Z","timestamp":1790948815719,"version":"4.1.0"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.neuroscience.2019.04.008","type":"journal-article","created":{"date-parts":[[2019,4,25]],"date-time":"2019-04-25T23:57:50Z","timestamp":1556236670000},"page":"180-194","source":"Crossref","is-referenced-by-count":50,"special_numbering":"C","title":["Effects of Muscarinic Acetylcholine m1 and m4 Receptor Blockade on Dyskinesia in the Hemi-Parkinsonian Rat"],"prefix":"10.1016","volume":"409","author":[{"given":"Nicole E.","family":"Chambers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha M.","family":"Meadows","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eitan","family":"Sheena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Lanza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa M.","family":"Conti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Bishop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2019.04.008_bb0005","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/mds.1090","article-title":"Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature","volume":"16","author":"Ahlskog","year":"2001","journal-title":"Mov Disord"},{"key":"10.1016\/j.neuroscience.2019.04.008_bb0010","doi-asserted-by":"crossref","DOI":"10.1002\/mds.27540","article-title":"Targeting the pedunculopontine nucleus in Parkinson's disease: time to go back to the drawing board","author":"Albin","year":"2018","journal-title":"Mov Dis"},{"key":"10.1016\/j.neuroscience.2019.04.008_bb0015","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/brain\/awq285","article-title":"Key role of striatal cholinergic interneurons in processes leading to arrest of motor stereotypies","volume":"134","author":"Aliane","year":"2011","journal-title":"Brain"},{"issue":"7","key":"10.1016\/j.neuroscience.2019.04.008_bb0020","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1093\/brain\/awl103","article-title":"Slow oscillatory activity and levodopa-induced dyskinesias in Parkinson's disease","volume":"129","author":"Alonso-French","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2019.04.008_bb0025","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.nbd.2013.09.020","article-title":"Immediate-early gene expression in structures outside the basal ganglia is associated to L-DOPA-induced dyskinesia","volume":"62","author":"Bastide","year":"2014","journal-title":"Neurobiol Dis"},{"issue":"14","key":"10.1016\/j.neuroscience.2019.04.008_bb0030","doi-asserted-by":"crossref","first-page":"5301","DOI":"10.1523\/JNEUROSCI.18-14-05301.1998","article-title":"A complex program of striatal gene expression induced by dopaminergic stimulation","volume":"181","author":"Berke","year":"1998","journal-title":"J Neurosci"},{"issue":"9","key":"10.1016\/j.neuroscience.2019.04.008_bb0035","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1523\/JNEUROSCI.12-09-03591.1992","article-title":"Phenotypical characterization of the rat striatal neurons expression muscarinic receptor genes","volume":"12","author":"Bernard","year":"1992","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2019.04.008_bb0040","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00213-007-0844-6","article-title":"The muscarinic receptor antagonist tropicamide suppresses tremulous jaw movements in a rodent model of parkinsonian tremor: possible role of M4 receptors","volume":"194","author":"Betz","year":"2007","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.neuroscience.2019.04.008_bb0045","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.neuroscience.2009.05.040","article-title":"Effects of the adenosine A2A antagonist KW 6002 (Istradefylline) on pimozide-induced oral tremor and striatal c-fos expression: comparisons with the muscarinic antagonist tropicamide","volume":"163","author":"Betz","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2019.04.008_bb0050","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1002\/jnr.21978","article-title":"Contribution of the striatum to the effects of 5-HT1A receptor stimulation in L-DOPA-treated hemiparkinsonian rats","volume":"87","author":"Bishop","year":"2009","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.neuroscience.2019.04.008_bb0055","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1212\/WNL.0b013e3181c1ded6","article-title":"History of falls in parkinson disease is associated with reduced cholinergic activity","volume":"73","author":"Bohnen","year":"2009","journal-title":"J Neurol"},{"key":"10.1016\/j.neuroscience.2019.04.008_bb0060","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1212\/WNL.0b013e3182a9f558","article-title":"Gait speed in parkinson disease correlates with cholinergic degeneration","volume":"81","author":"Bohnen","year":"2013","journal-title":"J Neurol"},{"key":"10.1016\/j.neuroscience.2019.04.008_bb0065","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.nbd.2016.02.019","article-title":"Optogenetic activation of striatal cholinergic interneurons regulates L-dopa-induced dyskinesias","volume":"91","author":"Bordia","year":"2016","journal-title":"Neurobiol Dis"},{"issue":"6","key":"10.1016\/j.neuroscience.2019.04.008_bb0070","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s00424-008-0473-x","article-title":"Muscarinic ACh receptor-mediated control of thalamic activity via Gq\/G11-family G-proteins","volume":"456","author":"Broicher","year":"2008","journal-title":"Eur J Physiol"},{"key":"10.1016\/j.neuroscience.2019.04.008_bb0075","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1093\/brain\/awm082","article-title":"Dopamine released from 5-HT terminals is the cause of L-dopa-induced dyskinesia in parkinsonian rats","volume":"130","author":"Carta","year":"2007","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.neuroscience.2019.04.008_bb0080","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/0471142301.ns0925s41","article-title":"Ratings of L-DOPA-induced dyskinesia in the unilateral 6-OHDA lesion model of Parkinson's disease in rats and mice","volume":"41","author":"Cenci","year":"2007","journal-title":"Curr Protoc Neurosci"},{"issue":"2","key":"10.1016\/j.neuroscience.2019.04.008_bb0085","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0306-4522(98)00217-6","article-title":"Biochemical and anatomical characterization of forepaw adjusting steps in rat models of Parkinson's disease: studies on medial forebrain bundle and striatal lesions","volume":"88","author":"Chang","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2019.04.008_bb0090","first-page":"46","article-title":"Cholinergic receptor alterations in the cerebral cortex of spinal cord injured rat","volume":"10","author":"Chinthu","year":"2017","journal-title":"Biochem Biophys Rep"},{"key":"10.1016\/j.neuroscience.2019.04.008_bb0095","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.neubiorev.2018.05.021","article-title":"A new outlook on cholinergic interneurons in Parkinson's disease and L-DOPA-induced dyskinesia","volume":"92","author":"Conti","year":"2018","journal-title":"Neurosci Biobehav Rev"},{"issue":"3917","key":"10.1016\/j.neuroscience.2019.04.008_bb0100","first-page":"899","article-title":"Antiparkinsonian drugs: inhibition of dopamine uptake in the corpus striatum as a possible mechanism of action","volume":"166","author":"Coyle","year":"1969","journal-title":"AAAS"},{"issue":"13","key":"10.1016\/j.neuroscience.2019.04.008_bb0105","doi-asserted-by":"crossref","first-page":"45009-4518","DOI":"10.1523\/JNEUROSCI.5071-13.2014","article-title":"A major external source of cholinergic innervation of the striatum and nucleus accumbens originates in the brainstem","volume":"34","author":"Dautan","year":"2014","journal-title":"J Neurosci"},{"issue":"23","key":"10.1016\/j.neuroscience.2019.04.008_bb0110","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1016\/0024-3205(96)00208-1","article-title":"Synthesis, characterization and pharmacological profile of tropicamide enantiomers","volume":"58","author":"Dei","year":"1996","journal-title":"Life Sci"},{"issue":"6","key":"10.1016\/j.neuroscience.2019.04.008_bb0115","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/nn1700","article-title":"RGS4-dependent attenuation of M4 autoreceptor function in striatal cholinergic interneurons following dopamine depletion","volume":"9","author":"Ding","year":"2006","journal-title":"Nat Neurosci"},{"issue":"2","key":"10.1016\/j.neuroscience.2019.04.008_bb0120","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.neuron.2010.06.017","article-title":"Thalamic gating of corticostriatal signaling by cholinergic interneurons","volume":"67","author":"Ding","year":"2010","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.neuroscience.2019.04.008_bb0125","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1073\/pnas.1006511108","article-title":"Enhanced striatal cholinergic neuronal activity mediates L-DOPA-induced dyskinesia in parkinsonian mice","volume":"108","author":"Ding","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.neuroscience.2019.04.008_bb0130","first-page":"727","article-title":"Antagonist binding profiles of five cloned human muscarinic receptor subtypes","volume":"256","author":"D\u00f6rje","year":"1991","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2019.04.008_bb0135","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1001\/archneur.1967.00470260014002","article-title":"Cholinergic-anticholinergic antagonism in parkinsonism","volume":"17","author":"Duvoisin","year":"1967","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neuroscience.2019.04.008_bb0140","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1016\/j.ins.2009.12.010","article-title":"Advanced nonparametric tests for multiple comparisons in the design of experiments in computational intelligence and data mining: experimental analysis of power","volume":"180","author":"Garcia","year":"2010","journal-title":"Inf Sci"},{"key":"10.1016\/j.neuroscience.2019.04.008_bb0145","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1124\/mol.114.093096","article-title":"Functional selectivity of allosteric interactions within G protein-coupled receptor oligomers: the dopamine D1-D3 receptor heterotetramer","volume":"86","author":"Guitart","year":"2014","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.neuroscience.2019.04.008_bb0150","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.neuroscience.2017.05.051","article-title":"Alterations of M1 and M4 acetlycholine receptors in the genetically dystonic (dtsz) hamster and moderate antidystonic efficacy of M1 and M4 anticholinergics","volume":"357","author":"Hamann","year":"2017","journal-title":"J Neurosci"},{"issue":"4","key":"10.1016\/j.neuroscience.2019.04.008_bb0155","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/mds.870080417","article-title":"Orobuccal dyskinesia associated with trihexyphenidyl therapy in a patient with parkinson's disease","volume":"8","author":"Hauser","year":"1993","journal-title":"Mov Dis"},{"key":"10.1016\/j.neuroscience.2019.04.008_bb0160","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/0024-3205(95)00030-A","article-title":"Diverse pre- and post-synatpic expression of m1-m4 muscarinic receptor proteins in neurons and afferents in the rat neostriatum","volume":"56","author":"Hersch","year":"1995","journal-title":"Life Sci"},{"issue":"4","key":"10.1016\/j.neuroscience.2019.04.008_bb0165","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0306-4522(94)90459-6","article-title":"An investigation into the role of the pedunculopontine tegmental nucleus in the mediation of locomotion and orofacial stereotypy induced by d-amphetamine and apomorphine in the rat","volume":"58","author":"Inglis","year":"1994","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2019.04.008_bb0170","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.expneurol.2012.07.005","article-title":"Gamma oscillations in the human basal ganglia","volume":"245","author":"Jenkinson","year":"2013","journal-title":"Exp Neurol"},{"issue":"176","key":"10.1016\/j.neuroscience.2019.04.008_bb0175","article-title":"Muscarinic modulation of high frequency oscillations in pedunculopontine neurons","volume":"4","author":"Kezunovic","year":"2013","journal-title":"Front Neurol"},{"key":"10.1016\/j.neuroscience.2019.04.008_bb0180","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1111\/j.1471-4159.1986.tb08506.x","article-title":"A semiautomated analysis method for catecholamines, indoleamines, and some prominent metabolites in microdissected regions of the nervous system: an isocratic HPLC technique employing coulometric detection and minimal sample preparation","volume":"46","author":"Kilpatrick","year":"1986","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2019.04.008_bb0185","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0014-2999(88)90417-7","article-title":"Stereoselectivity of the enantiomers of trihexyphenidyl and its methiodide at muscarinic receptor subtypes","volume":"155","author":"Lambrecht","year":"1988","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2019.04.008_bb0190","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.pharmthera.2007.09.009","article-title":"Muscarinic acetylcholine receptors as CNS drug targets","volume":"117","author":"Langmead","year":"2008","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.neuroscience.2019.04.008_bb0195","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.neuropharm.2018.06.024","article-title":"Behavioral and cellular dopamine D1 and D3 receptor-mediated synergy: implications for L-DOPA-induced dyskinesia","volume":"138","author":"Lanza","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuroscience.2019.04.008_bb0200","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1111\/j.1476-5381.1993.tb13738.x","article-title":"Pharmacological characterization of acetylcholine-stimulated [35S]-GTP\u03d2S binding medicated by human muscarinic m1-m4 receptors: antagonist studies","volume":"109","author":"Lazareno","year":"1993","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.neuroscience.2019.04.008_bb0205","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.nbd.2015.01.003","article-title":"Enhanced histamine H2 excitation of striatal cholinergic interneurons in L-DOPA-induced dyskinesia","volume":"76","author":"Lim","year":"2015","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuroscience.2019.04.008_bb0210","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0006-8993(97)00928-1","article-title":"Locomotion and stereotypy induced by scopolamine: contribution of muscarinic receptors near the pedunculopontine tegmental nucleus","volume":"775","author":"Mathur","year":"1997","journal-title":"Brain Res"},{"issue":"3","key":"10.1016\/j.neuroscience.2019.04.008_bb0215","first-page":"354","article-title":"The dual mode of the antispasmodic effect of dicyclomine hydrochloride","volume":"146","author":"McGrath","year":"1964","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2019.04.008_bb0220","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.expneurol.2017.03.013","article-title":"Characterizing the differential roles of striatal 5-HT1A auto- and hetero-receptors in the reduction of L-DOPA-induced dyskinesia","volume":"292","author":"Meadows","year":"2017","journal-title":"Exp Neurol"},{"issue":"1","key":"10.1016\/j.neuroscience.2019.04.008_bb0225","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.neuron.2017.02.027","article-title":"Rethinking the pedunculopontine nucleus: from cellular organization to function","volume":"94","author":"Mena-Segovia","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.neuroscience.2019.04.008_bb0230","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.neuron.2017.12.008","article-title":"Cholinergic projections to the substantia nigra pars reticulata inhibit dopamine modulation of basal ganglia through the M4 muscarinic receptor","volume":"96","author":"Moehle","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.neuroscience.2019.04.008_bb0235","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1021\/cn500003z","article-title":"M4 mAChR-mediated modulation of glutamatergic transmission at corticostriatal synapses","volume":"5","author":"Pancani","year":"2014","journal-title":"ACS Chem Nerosci"},{"key":"10.1016\/j.neuroscience.2019.04.008_bb0240","series-title":"The rat brain atlas in stereotactic coordinates","author":"Paxinos","year":"1998"},{"issue":"1","key":"10.1016\/j.neuroscience.2019.04.008_bb0245","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1124\/jpet.107.126219","article-title":"Evaluation of levodopa dose and magnitude of dopamine depletion as risk factors for levodopa-induced dyskinesia in a rat model of Parkinson's disease","volume":"323","author":"Putterman","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10.1016\/j.neuroscience.2019.04.008_bb0250","doi-asserted-by":"crossref","DOI":"10.1097\/00008877-199304000-00006","article-title":"Pharmacological characterization of the discriminative stimulus properties of the dopamine D1 agonist, SKF81297","volume":"4","author":"Reavill","year":"1993","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.neuroscience.2019.04.008_bb0255","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0014-2999(91)90796-S","article-title":"Dopamine receptors labelled by [3H]quinpirole","volume":"203","author":"Seeman","year":"1991","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2019.04.008_bb0260","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.neuron.2015.10.039","article-title":"M4 muscarinic receptor signaling ameliorates striatal plasticity deficits in models of L-DOPA-induced dyskinesia","volume":"88","author":"Shen","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.neuroscience.2019.04.008_bb0265","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1073\/pnas.88.6.2608","article-title":"Distinct muscarinic receptors inhibit release of \u03b3-aminobutyric acid and excitatory amino acids in the mammalian brain","volume":"88","author":"Sugita","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.neuroscience.2019.04.008_bb0270","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/mds.27098","article-title":"Pedunculopontine nucleus deep brain stimulation in Parkinon's disease: a clinical review","volume":"33","author":"Thevathasan","year":"2018","journal-title":"Mov Dis"},{"issue":"2","key":"10.1016\/j.neuroscience.2019.04.008_bb0275","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0306-4522(92)90253-X","article-title":"Muscarinic M2 receptor mRNA expression and receptor binding in cholinergic and non-cholinergic cells in the rat brain: a correlative study using in situ hybridization histochemistry and receptor autoradiography","volume":"47","author":"Vilar\u00f3","year":"1992","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2019.04.008_bb0280","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/0169-328X(94)90375-1","article-title":"Multiplicity of muscarinic autoreceptors subtypes? Comparison of the distribution of cholinergic cells containing mRNA for five subtypes of muscarinic receptors in the rat brain","volume":"21","author":"Vilar\u00f3","year":"1994","journal-title":"Mol Brain Res"},{"issue":"3","key":"10.1016\/j.neuroscience.2019.04.008_bb0285","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/0306-4522(95)00597-8","article-title":"Scopolamine augments c-fos and zif\/268 messenger RNA expression induced by the full D1 dopamine receptor agonist SKF82958 in the intact rat striatum","volume":"72","author":"Wang","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2019.04.008_bb0290","doi-asserted-by":"crossref","first-page":"7050","DOI":"10.1073\/pnas.87.18.7050","article-title":"Expression of muscarinic acetylcholine and dopamine receptor mRNAs in rat basal ganglia","volume":"87","author":"Weiner","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2019.04.008_bb0295","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1523\/JNEUROSCI.2888-13.2014","article-title":"Striatal cholinergic cell ablation attenuates L-DOPA-induced dyskinesia in parkinsonian mice","volume":"34","author":"Won","year":"2014","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2019.04.008_bb0300","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.bmcl.2016.11.086","article-title":"Challenges in the development of an M4 PAM in vivo tool compound: the discovery of VU0467154 and unexpected DMPK profiles of close analogs","volume":"27","author":"Wood","year":"2017","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.neuroscience.2019.04.008_bb0305","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.neuron.2016.03.028","article-title":"Cholinergic mesopontine signals govern locomotion and reward through dissociable midbrain pathways","volume":"90","author":"Xiao","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.neuroscience.2019.04.008_bb0310","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.neulet.2017.08.016","article-title":"Selective cholinergic depletion of pedunculopontine tegmental nucleus aggravates freezing of gait in parkinsonian rats","volume":"659","author":"Xiao","year":"2017","journal-title":"Neurosci Lett"},{"issue":"4","key":"10.1016\/j.neuroscience.2019.04.008_bb0315","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/S0306-4522(01)00039-2","article-title":"Coordinated expression of muscarinic receptor messenger RNAs in striatal medium spiny neurons","volume":"103","author":"Yan","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2019.04.008_bb0320","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1152\/jn.01143.2009","article-title":"Cholinergic modulation of fast inhibitory and excitatory transmission to pedunculopontine thalamic projecting neurons","volume":"103","author":"Ye","year":"2010","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.neuroscience.2019.04.008_bb0325","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1073\/pnas.88.4.1291","article-title":"Cocaine induces striatal c-fos-immunoreactive proteins via dopaminergic D1 receptors","volume":"88","author":"Young","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"71","key":"10.1016\/j.neuroscience.2019.04.008_bb0330","first-page":"1","article-title":"Involvement of HCN channel in muscarinic inhibitory action on tonic firing of dorsolateral striatal cholinergic interneurons","volume":"10","author":"Zhao","year":"2016","journal-title":"Front Cell Neurosci"},{"issue":"35","key":"10.1016\/j.neuroscience.2019.04.008_bb0335","doi-asserted-by":"crossref","first-page":"9161","DOI":"10.1523\/JNEUROSCI.0873-16.2016","article-title":"Involvement of striatal cholinergic interneurons and M1 and M4 muscarinic receptors in motor symptoms of Parkinson's disease","volume":"36","author":"Ztaou","year":"2016","journal-title":"J Neurosci"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452219302489?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452219302489?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,12,8]],"date-time":"2020-12-08T01:37:56Z","timestamp":1607391476000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452219302489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":67,"alternative-id":["S0306452219302489"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2019.04.008","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]}}}